Benzinga | Oct 19, 2020 09:07AM EDT

Cantor Fitzgerald Initiates Coverage On Aptose Biosciences with Overweight Rating, Announces Price Target of C$10

Cantor Fitzgerald analyst Alethia Young initiates coverage on Aptose Biosciences (TSX:APS) with a Overweight rating and announces Price Target of C$10.